Special lenses could slow worsening eyesight in kids

NCT ID NCT05888792

Ongoing Disease control Sponsor: The Hong Kong Polytechnic University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new type of spectacle lens (DG2) designed to slow down nearsightedness (myopia) in children whose vision is getting worse quickly. 118 children aged 4–13 will wear these lenses for 4 years. Researchers will measure changes in their eye prescription and eye length every 6 months to see if the lenses effectively control myopia progression.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Defocus Incorporated Multiple Segments spectacle lens (DG2)
What this could lead to: If successful, these lenses could offer a simple, non-invasive way to slow worsening nearsightedness in children, potentially reducing the risk of serious eye diseases later in life.
What could go wrong: This is a relatively small study (118 children) and results may not apply to all kids. The lenses only slow progression, not stop or reverse it, and long-term benefits beyond 4 years are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOPIA

Contacts and locations

Locations

School of Optometry, The Hong Kong Polytechnic University

Hung Hom, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.